Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Tim Church, the chief medical officer at Wondr Health, a weight-management company that works with employers, said he gets why patients would want to go the compounding route, given how many need medication and can't afford it
Per the company's website, AgelessRx states it was a semi-finalist in the XPRIZE Healthspan competition
CIRS vs Mycotoxin Illness CIRS: Broad biomarker dysregulation Persistent innate immune activation Non-CIRS Mycotoxin Illness: Selective biomarker abnormalities May include immune sensitization without full systemic dysregulation This patients profile aligned with the latter
FDA approval in the US is expected in 2026 to 2027, with Health Canada approval likely following
Because theyre considered natural nutritional boosters as opposed to actual drugs, brands (and people) can claim a lot about them without having much evidence to back it up
This question has sparked widespread interest, especially among health enthusiasts and those looking to optimize their wellness routines
